-
EP4282484
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4282484
| EP4282484 - BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.12.2024 Database last updated on 07.03.2026 | |
| Former | The application has been published Status updated on 27.10.2023 | Most recent event Tooltip | 20.12.2024 | Application deemed to be withdrawn | published on 22.01.2025 [2025/04] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 & Province Line Road Princeton, NJ 08543 / US | [2023/48] | Inventor(s) | 01 /
VU, Minh Diem 8832 Wollerau / CH | 02 /
STREIN, Klaus 69469 Weinheim / DE | 03 /
HUNZIKER, Erich 8832 Wilen / CH | [2023/48] | Representative(s) | Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | [N/P] |
| Former [2023/48] | Redhouse, Juliet Lauren Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | Application number, filing date | 23183309.6 | 02.12.2015 | [2023/48] | Priority number, date | EP20140196168 | 03.12.2014 Original published format: EP 14196168 | [2023/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP4282484 | Date: | 29.11.2023 | Language: | EN | [2023/48] | Type: | A3 Search report | No.: | EP4282484 | Date: | 28.02.2024 | Language: | EN | [2024/09] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 26.01.2024 | Classification | IPC: | C07K16/28, G01N33/574, A61P35/00 | [2024/09] | CPC: |
C07K16/2809 (EP,CN,KR,US);
A61P19/02 (EP);
A61P29/00 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
C07K16/2878 (EP,CN,KR,US);
G01N33/57557 (EP,CN,KR,US);
G01N33/6863 (EP,CN,KR,US);
C07K2317/31 (EP,CN,KR,US);
C07K2317/33 (EP,CN,KR,US);
C07K2317/73 (EP,CN,KR,US);
C07K2317/92 (EP,CN,KR,US);
|
| Former IPC [2023/48] | A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/48] | Title | German: | BISPEZIFISCHE ANTIKÖRPER GEGEN CD3-EPSILON UND BCMA UND ZUR VERWENDUNG BEI DER BEHANDLUNG VON KRANKHEITEN | [2023/48] | English: | BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND BCMA FOR USE IN TREATMENT OF DISEASES | [2023/48] | French: | ANTICORPS BISPÉCIFIQUES DIRIGÉS CONTRE CD3EPSILON ET BCMA À UTILISER DANS LE TRAITEMENT DE MALADIES | [2023/48] | Examination procedure | 29.08.2024 | Application deemed to be withdrawn, date of legal effect [2025/04] | 18.09.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2025/04] | Parent application(s) Tooltip | EP15804458.6 / EP3227333 | Fees paid | Renewal fee | 09.10.2023 | Renewal fee patent year 03 | 09.10.2023 | Renewal fee patent year 04 | 09.10.2023 | Renewal fee patent year 05 | 09.10.2023 | Renewal fee patent year 06 | 09.10.2023 | Renewal fee patent year 07 | 09.10.2023 | Renewal fee patent year 08 | 15.11.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ID] WO2013072406 (AMGEN RES MUNICH GMBH et al.) | [ID] WO2014140248 (AMGEN RES MUNICH GMBH et al.) | [ID] WO2014122143 (ENGMAB AG et al.) | [AD] WO2009032058 (EVEREADY BATTERY INC et al.) | [AD] WO2012143498 (BOEHRINGER INGELHEIM INT et al.) | [A] ERIC SANCHEZ ET AL: "Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival", BRITISH JOURNAL OF HAEMATOLOGY, vol. 158, no. 6, 18 July 2012 (2012-07-18), pages 727 - 738, XP055186278, ISSN: 0007-1048, DOI: 10.1111/j.1365-2141.2012.09241.x DOI: http://dx.doi.org/10.1111/j.1365-2141.2012.09241.x | by applicant | WO2012143498 | WO2009032058 | WO2014089335 | WO0041474 | WO0124811 | WO0124812 | WO2010104949 | WO2012163805 | WO02066516 | WO2013154760 | WO2007117600 | WO2009132058 | WO2012066058 | WO2013072415 | WO2014122143 | WO2014122144 | WO2013072406 | WO2014140248 | EP14179705 | EP14194151 | EP0307434 | WO2012130831 | US5202238 | US5204244 | RICKERT RC ET AL., IMMUNOL REV, vol. 244, no. 1, 2011, pages 115 - 133 | NOVAK AJ ET AL., BLOOD, vol. 103, 2004, pages 689 - 694 | LI ET AL., MED ONCOL, vol. 27, 2010, pages 439 - 445 | DISPENZIERI ET AL., MAYO CLIN PROC, vol. 82, no. 3, 2007, pages 323 - 341 | O'CONNOR ET AL., J EXP MED., vol. 199, 2004, pages 91 - 98 | SANCHEZ E ET AL., BR J HAEMATOLOGY, vol. 158, 2012, pages 727 - 38 | "UniProt", Database accession no. P07766 | YANG SJ, THE JOURNAL OF IMMUNOLOGY, vol. 137, 1986, pages 1097 - 1100 | ANASETTI ET AL., TRANSPLANTATION, vol. 54, 1992, pages 844 | KONTERMANN RE, MABS, vol. 4, no. 2, 2012, pages 1 - 16 | GRAS M-P. ET AL., INT IMMUNOL, vol. 7, 1995, pages 1093 - 1106 | RYAN, MC ET AL., MOL. CANCER THER, vol. 6, 2007, pages 3009 - 3018 | TOPP ET AL., J CLIN ONCOL, vol. 29, no. 18, 2011, pages 2493 - 8 | O'CONNOR ET AL., J EXP MED, vol. 199, no. 1, 2004, pages 91 - 8 | MOREAUX ET AL., BLOOD, vol. 103, no. 8, 2004, pages 3148 - 3157 | RYAN ET AL., MOL CANCER THER, vol. 6, no. 11, 2007, pages 3009 - 18 | MATTHES ET AL., BLOOD, vol. 118, no. 7, 2011, pages 1838 - 1844 | CARPENTER ET AL., BLOOD, vol. 19, no. 8, 2013, pages 2048 - 60 | FRIGYESI ET AL., BLOOD, vol. 123, no. 29, 2014, pages 3128 - 28 | CLAUDIO ET AL., BLOOD, vol. 100, no. 6, 2002, pages 2175 - 86 | TAI ET AL., CANCER RES, vol. 123, no. 20, 2006, pages 3128 - 38 | JU ET AL., CLIN BIOCHEM, vol. 42, no. 4-5, 2009, pages 387 - 99 | MOREAUX ET AL., EUR J HAEMATOL, vol. 83, no. 2, 2009, pages 119 - 29 | DREIER ET AL., INT J CANCER, 2002 | KLINGER ET AL., BLOOD, 2012 | GOEBELER ET AL., ANN ONCOL, 2011 | RIECHMANN, L. ET AL., NATURE, vol. 332, 1988, pages 323 - 327 | HEZAREH, M. ET AL., J. VIROL., vol. 75, 2001, pages 12161 - 12168 | PEREZNOLAN, NAT BIOTECHNOL, vol. 20, no. 2, 2002, pages 155 - 62 | WOOF JBURTON D, NAT REV IMMUNOL, vol. 4, 2004, pages 89 - 99 | LUKAS, TJ. ET AL., J. IMMUNOL., vol. 127, 1981, pages 2555 - 2560 | BRUNHOUSE, R.CEBRA, J.J., MOL. IMMUNOL., vol. 16, 1979, pages 907 - 917 | BURTON, D.R. ET AL., NATURE, vol. 288, 1980, pages 338 - 344 | THOMMESEN, J.E. ET AL., MOL. IMMUNOL., vol. 37, 2000, pages 995 - 1004 | IDUSOGIE, E.E. ET AL., J. IMMUNOL., vol. 164, 2000, pages 4178 - 4184 | MORGAN, A. ET AL., IMMUNOLOGY, vol. 86, 1995, pages 319 - 324 | SONDERMANN ET AL., NATURE, vol. 406, 20 July 2000 (2000-07-20), pages 267 - 273 | MORRISON, S.L. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 81, 1984, pages 6851 - 6855 | NEUBERGER, M.S. ET AL., NATURE, vol. 314, 1985, pages 268 - 270 | VAN DIJK, M.A.VAN DE WINKEL, J.G., CURR. OPIN. CHEM. BIOL., vol. 5, 2001, pages 368 - 374 | JAKOBOVITS, A. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 2551 - 2555 | JAKOBOVITS, A. ET AL., NATURE, vol. 362, 1993, pages 255 - 258 | BRUGGEMANN, M. ET AL., YEAR IMMUNOL., vol. 7, 1993, pages 33 - 40 | HOOGENBOOM, H.R.WINTER, G., J. MOL. BIOL., vol. 227, 1992, pages 381 - 388 | MARKS, J.D. ET AL., J. MOL. BIOL., vol. 222, 1991, pages 581 - 597 | COLE ET AL.: "Monoclonal Antibodies and Cancer Therapy", 1985, ALAN R. LISS, pages: 77 | BOERNER, P. ET AL., J. IMMUNOL., vol. 147, 1991, pages 86 - 95 | KABAT ET AL.: "Sequences of Proteins of Immunological Interest", 1991, PUBLIC HEALTH SERVICE, NATIONAL INSTITUTES OF HEALTH | "Current Protocols in Molecular Biology", 1987, GREENE PUBLISHING AND WILEY INTERSCIENCE | INAKILEE, NAT REV RHEUMATOL, vol. 6, 2010, pages 326 - 337 | RYAN, MC ET AL., MOL. CANCER THER., vol. 6, 2007, pages 3009 - 3018 | NOVAK AJ ET AL., BLOOD, vol. 103, no. 2, 25 September 2003 (2003-09-25), pages 689 - 94 | MAUS MVJUNE CH, CLIN CANCER RES, vol. 19, 2013, pages 2048 - 60 | RAWSTRON AC ET AL.: "Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders", HAEMATOLOGICA, vol. 93, 2008, pages 431 - 438 | TAE-DONG JEONG ET AL., KOREAN J HEMATOL, vol. 47, no. 4, December 2012 (2012-12-01), pages 260 - 266 | "Current Protocols in Cell Biology", 2000, JOHN WILEY & SONS, INC | SANCHEZ ET AL., BRIT J HAEMATOL, 2012 | BARGOU ET AL., SCIENCE, vol. 321, no. 5891, 2008, pages 974 - 7 | KOYAMA ET AL., ANN RHEUM DIS, vol. 64, 2005, pages 1065 - 1067 | LAFARGE ET AL., BMC MOLECULAR BIOL, vol. 8, 2007, pages 64 |